ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BHVN Biohaven Ltd

40.69
0.79 (1.98%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Biohaven Ltd BHVN NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.79 1.98% 40.69 09:00:00
개장가 저가 고가 종가 전일 종가
40.72 40.45 42.105 40.69 39.90
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202405:05PRNUSBiohaven Announces Closing of Public Offering and Full..
18/04/202405:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
13/04/202422:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
01/03/202406:16EDGAR2Form 8-K - Current report
01/03/202406:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
08/01/202421:30EDGAR2Form 8-K - Current report
08/01/202421:30PRNUSBiohaven Highlights Progress Across Innovative Portfolio and..
02/01/202421:00PRNUSBiohaven to Present at the 42nd Annual J.P. Morgan..
02/12/202306:30PRNUSBiohaven Presents Expanded EEG and Safety Data for BHV-7000..
15/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202306:05PRNUSBiohaven Reports Third Quarter 2023 Financial Results and..
16/10/202320:00PRNUSBiohaven Presents Preclinical Data Demonstrating..
06/10/202305:05EDGAR2Form 8-K - Current report
06/10/202305:05PRNUSBiohaven Announces Closing of Public Offering and Full..
05/10/202305:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202312:56PRNUSBiohaven Announces Pricing of $225 Million Public Offering..
03/10/202310:41EDGAR2Form 8-K - Current report
03/10/202306:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202306:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202305:36PRNUSBIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
03/10/202305:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/09/202319:58EDGAR2Form 8-K - Current report
14/09/202320:00PRNUSBiohaven Completes Enrollment in Pivotal Phase 3 Study of..
05/09/202320:00PRNUSBiohaven Announces Positive Data from its Exploratory..
01/08/202306:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202305:29EDGAR2Form 8-K - Current report
31/07/202322:31PRNUSBiohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
31/07/202319:59PRNUSBiohaven Reports Second Quarter 2023 Financial Results and..
29/07/202305:35EDGAR2Form 8-K - Current report
27/07/202321:42DJNBiohaven Told That FDA Won't Review NDA Application for..
27/07/202320:00PRNUSBiohaven Provides Preliminary EEG Data Update for Kv7..
31/05/202320:00PRNUSBiohaven Provides Overview of Clinical Progress, Regulatory..
26/05/202306:00PRNUSBiohaven to Present R&D Day at Yale School of Management
13/05/202305:30PRNUSBiohaven Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock